Theriva Biologics, Inc. financial data

Symbol
TOVX on NYSE
Industry
Pharmaceutical Preparations
Location
9605 Medical Center Drive, Suite 270, Rockville, MD
State of incorporation
NV
Fiscal year end
December 31
Former names
Synthetic Biologics, Inc. (to 10/12/2022), ADEONA PHARMACEUTICALS, INC. (to 2/17/2012), PIPEX PHARMACEUTICALS, INC. (to 10/16/2008), SHEFFIELD PHARMACEUTICALS INC (to 12/8/2006), SHEFFIELD MEDICAL TECHNOLOGIES INC (to 5/14/1997)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 328 % -30.6%
Return On Equity -33 % -65.8%
Return On Assets -24.7 % -30.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.78M shares -83.7%
Common Stock, Shares, Outstanding 2.62M shares -84.6%
Entity Public Float 32.7M USD -58.7%
Common Stock, Value, Issued 3K USD -83.3%
Weighted Average Number of Shares Outstanding, Basic 1.13M shares +66.4%
Weighted Average Number of Shares Outstanding, Diluted 1.13M shares +66.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 13.3M USD +1.17%
General and Administrative Expense 7.72M USD -17.4%
Operating Income (Loss) -28M USD -24.2%
Nonoperating Income (Expense) 867K USD -40.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -27.1M USD -28.6%
Income Tax Expense (Benefit) -1.64M USD -15.1%
Net Income (Loss) Attributable to Parent -3.3M USD +26.4%
Earnings Per Share, Basic -3.19 USD/shares +46%
Earnings Per Share, Diluted -3.19 USD/shares +46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.4M USD -47.3%
Assets, Current 19.5M USD -43.8%
Property, Plant and Equipment, Net 314K USD -19.3%
Operating Lease, Right-of-Use Asset 1.43M USD -22%
Intangible Assets, Net (Excluding Goodwill) 18.7M USD -1.45%
Goodwill 1.47M USD -73.9%
Assets 40.1M USD -34.8%
Accounts Payable, Current 756K USD -9.24%
Employee-related Liabilities, Current 1.29M USD +1.73%
Accrued Liabilities, Current 3.75M USD -32.8%
Contract with Customer, Liability, Current 906K USD
Liabilities, Current 7.32M USD -16.2%
Contract with Customer, Liability, Noncurrent 906K USD
Deferred Income Tax Liabilities, Net 413K USD -79.2%
Operating Lease, Liability, Noncurrent 1.04M USD -33.1%
Liabilities 15.5M USD -12.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 112K USD
Retained Earnings (Accumulated Deficit) -331M USD -8.79%
Stockholders' Equity Attributable to Parent 56.4M USD -23.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 24.6M USD -40.1%
Liabilities and Equity 40.1M USD -34.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.88M USD +13%
Net Cash Provided by (Used in) Financing Activities -55K USD +96%
Net Cash Provided by (Used in) Investing Activities -8K USD +99.8%
Common Stock, Shares Authorized 14M shares -96%
Common Stock, Shares, Issued 2.65M shares -85.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.92M USD +13.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.5M USD -47.2%
Deferred Tax Assets, Valuation Allowance 28.4M USD +15.4%
Deferred Tax Assets, Gross 33.3M USD +20.2%
Operating Lease, Liability 1.58M USD -21.5%
Payments to Acquire Property, Plant, and Equipment 8K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20.4M USD -42.7%
Lessee, Operating Lease, Liability, to be Paid 1.8M USD -26.1%
Property, Plant and Equipment, Gross 1.24M USD -7.94%
Operating Lease, Liability, Current 541K USD +17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 588K USD -10.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 673K USD +318%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 220K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 369K USD -44.4%
Deferred Tax Assets, Operating Loss Carryforwards 27.4M USD +23%
Lessee, Operating Lease, Liability, to be Paid, Year Four 368K USD +3.08%
Operating Lease, Payments 480K USD +51.4%
Depreciation, Depletion and Amortization 39K USD +21.9%
Deferred Tax Assets, Net of Valuation Allowance 4.99M USD +57.5%